GlassScriptPhysician profile
Taylor Raye Powell
NPI 1801667464
$966.09
in general payments reported to CMS, 2019-2025
10 companies · $692 in 2025
The $692 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $60.33 · 2024: $213 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.96 | 2025 | Ozempic, Rybelsus |
| Sequel Med Tech, LLC | $156.34 | 2025 | Twiist |
| Lilly USA, LLC | $148.64 | 2022-2024 | Mounjaro |
| Corcept Therapeutics | $125.00 | 2024 | Korlym |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Radius Health, INC. | $50.56 | 2025 | Tymlos |
| Medtronic, INC. | $32.41 | 2025 | Minimed 780g |
| Insulet Corporation | $26.70 | 2025 | Omnipod |
| Beta Bionics, INC. | $24.84 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ascensia Diabetes Care US INC. | $22.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.